{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T18:27:33Z","timestamp":1782325653928,"version":"3.54.5"},"reference-count":29,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.3201\/eid3206.260240","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:59:51Z","timestamp":1778853591000},"source":"Crossref","is-referenced-by-count":1,"title":["Cerebrospinal Fluid Findings among Patients with Anaplasmosis and Central Nervous Involvement, Minnesota and Wisconsin, USA"],"prefix":"10.3201","volume":"32","author":[{"given":"Igor","family":"Dumic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles W.","family":"Nordstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar B.","family":"Dugani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronin Joshua","family":"Cosiquien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Gavrancic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Paulson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Madrid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendelyn","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid3206.260240-202605150959-R1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/cid\/ciaf171","article-title":"Trends in anaplasmosis over the past decade: a review of clinical features, laboratory data, and outcomes.","volume":"82","author":"Katragadda","year":"2026","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid3206.260240-202605150959-R2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6502a1","article-title":"Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis\u2014United States.","volume":"65","author":"Biggs","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"key-10.3201\/eid3206.260240-202605150959-R3","doi-asserted-by":"publisher","first-page":"ofad193","DOI":"10.1093\/ofid\/ofad193","article-title":"Anaplasmosis in Pennsylvania: clinical features, diagnosis, and outcomes of patients diagnosed with Anaplasma phagocytophilum infection at Hershey Medical Center from 2008 to 2021.","volume":"10","author":"Ingram","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"key-10.3201\/eid3206.260240-202605150959-R4","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.idc.2022.02.008","article-title":"Human granulocytic anaplasmosis.","volume":"36","author":"MacQueen","year":"2022","journal-title":"Infect Dis Clin North Am"},{"key":"key-10.3201\/eid3206.260240-202605150959-R5","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.3390\/microorganisms10071433","article-title":"Human granulocytic anaplasmosis\u2014a systematic review of published cases.","volume":"10","author":"Dumic","year":"2022","journal-title":"Microorganisms"},{"key":"key-10.3201\/eid3206.260240-202605150959-R6","doi-asserted-by":"publisher","first-page":"e0012313","DOI":"10.1371\/journal.pntd.0012313","article-title":"Human granulocytotropic anaplasmosis\u2014a systematic review and analysis of the literature.","volume":"18","author":"Schudel","year":"2024","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.3201\/eid3206.260240-202605150959-R7","doi-asserted-by":"publisher","first-page":"101763","DOI":"10.1016\/j.ttbdis.2021.101763","article-title":"Anaplasmosis in Poland\u2014analysis of 120 patients.","volume":"12","author":"Moniuszko-Malinowska","year":"2021","journal-title":"Ticks Tick Borne Dis"},{"key":"key-10.3201\/eid3206.260240-202605150959-R8","doi-asserted-by":"publisher","first-page":"e77877","DOI":"10.7759\/cureus.77877","article-title":"Neurologic manifestation of anaplasmosis: a case report.","volume":"17","author":"Guru","year":"2025","journal-title":"Cureus"},{"key":"key-10.3201\/eid3206.260240-202605150959-R9","doi-asserted-by":"publisher","first-page":"e254603","DOI":"10.1136\/bcr-2023-254603","article-title":"Anaplasmosis encephalitis and infection of non-myeloid bone marrow precursors.","volume":"16","author":"Sohani","year":"2023","journal-title":"BMJ Case Rep"},{"key":"key-10.3201\/eid3206.260240-202605150959-R10","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3390\/idr15040035","article-title":"Anaplasma phagocytophilum encephalitis: a case report and literature review of neurologic manifestations of anaplasmosis.","volume":"15","author":"Cosiquien","year":"2023","journal-title":"Infect Dis Rep"},{"key":"key-10.3201\/eid3206.260240-202605150959-R11","doi-asserted-by":"publisher","first-page":"e21668","DOI":"10.7759\/cureus.21668","article-title":"Trigeminal neuralgia as the principal manifestation of anaplasmosis: a case report.","volume":"14","author":"LeDonne","year":"2022","journal-title":"Cureus"},{"key":"key-10.3201\/eid3206.260240-202605150959-R12","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/WNO.0000000000001599","article-title":"A case of opsoclonus-myoclonus-ataxia with neuronal intermediate filament IgG detected in cerebrospinal fluid.","volume":"42","author":"Merati","year":"2022","journal-title":"J Neuroophthalmol"},{"key":"key-10.3201\/eid3206.260240-202605150959-R13","doi-asserted-by":"publisher","first-page":"21501327211005895","DOI":"10.1177\/21501327211005895","article-title":"A case of anaplasmosis during a warm Minnesota fall.","volume":"12","author":"Khera","year":"2021","journal-title":"J Prim Care Community Health"},{"key":"key-10.3201\/eid3206.260240-202605150959-R14","doi-asserted-by":"publisher","first-page":"e243665","DOI":"10.1136\/bcr-2021-243665","article-title":"Central nervous system involvement of anaplasmosis.","volume":"14","author":"Mullholand","year":"2021","journal-title":"BMJ Case Rep"},{"key":"key-10.3201\/eid3206.260240-202605150959-R15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s12879-018-3321-4","article-title":"Manifestation of anaplasmosis as cerebral infarction: a case report.","volume":"18","author":"Kim","year":"2018","journal-title":"BMC Infect Dis"},{"key":"key-10.3201\/eid3206.260240-202605150959-R16","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1111\/j.1468-1331.2006.01582.x","article-title":"Encephalopathy with seizures having PCR\u2010positive Anaplasma phagocytophilum and Ehrlichia chaffeensis.","volume":"14","author":"Young","year":"2007","journal-title":"Eur J Neurol"},{"key":"key-10.3201\/eid3206.260240-202605150959-R17","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/j.1939-1676.2009.0466.x","article-title":"Evaluation of brain tissue or cerebrospinal fluid with broadly reactive polymerase chain reaction for Ehrlichia, Anaplasma, spotted fever group Rickettsia, Bartonella, and Borrelia species in canine neurological diseases (109 cases).","volume":"24","author":"Barber","year":"2010","journal-title":"J Vet Intern Med"},{"key":"key-10.3201\/eid3206.260240-202605150959-R18","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1128\/CMR.00007-10","article-title":"Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections.","volume":"23","author":"Nau","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"key-10.3201\/eid3206.260240-202605150959-R19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/idr16020012","article-title":"Hemophagocytic lymphohistiocytosis (HLH) in patients with tick-borne illness: a scoping review of 98 cases.","volume":"16","author":"Jevtic","year":"2024","journal-title":"Infect Dis Rep"},{"key":"key-10.3201\/eid3206.260240-202605150959-R20","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid3206.260240-202605150959-R21","doi-asserted-by":"publisher","first-page":"bcr2016219054","DOI":"10.1136\/bcr-2016-219054","article-title":"Cerebral haemorrhage as a clinical manifestation of human ehrlichiosis.","volume":"2017","author":"Garc\u00eda-Baena","year":"2017","journal-title":"BMJ Case Rep"},{"key":"key-10.3201\/eid3206.260240-202605150959-R22","doi-asserted-by":"publisher","first-page":"e01073","DOI":"10.1016\/j.idcr.2021.e01073","article-title":"Severe anaplasmosis presenting as possible CVA: case report and 3-year Anaplasma infection diagnosis data is based on PCR testing and serology.","volume":"24","author":"Eldaour","year":"2021","journal-title":"IDCases"},{"key":"key-10.3201\/eid3206.260240-202605150959-R23","doi-asserted-by":"publisher","first-page":"e0334957","DOI":"10.1371\/journal.pone.0334957","article-title":"Comparison of the epidemiological and clinical fingerprints of human granulocytotropic anaplasmosis and human monocytotropic ehrlichiosis in the United States.","volume":"20","author":"Kositz","year":"2025","journal-title":"PLoS One"},{"key":"key-10.3201\/eid3206.260240-202605150959-R24","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/ajcp\/aqae126","article-title":"Culture and other direct detection methods to diagnose human granulocytic anaplasmosis.","volume":"163","author":"Aguero-Rosenfeld","year":"2025","journal-title":"Am J Clin Pathol"},{"key":"key-10.3201\/eid3206.260240-202605150959-R25","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.amjmed.2024.11.025","article-title":"Antibodies to Anaplasma phagocytophilum in patients with human granulocytic anaplasmosis confirmed by both polymerase chain reaction and culture.","volume":"138","author":"Wormser","year":"2025","journal-title":"Am J Med"},{"key":"key-10.3201\/eid3206.260240-202605150959-R26","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1086\/317466","article-title":"Human granulocytic ehrlichiosis presenting as facial diplegia in a 42-year-old woman.","volume":"31","author":"Lee","year":"2000","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid3206.260240-202605150959-R27","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.3201\/eid3112.250946","article-title":"Retrospective multicenter study of human granulocytic anaplasmosis, France, 2012\u20132024.","volume":"31","author":"Gerber","year":"2025","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid3206.260240-202605150959-R28","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1186\/s13071-019-3852-6","article-title":"A review on the eco-epidemiology and clinical management of human granulocytic anaplasmosis and its agent in Europe.","volume":"12","author":"Matei","year":"2019","journal-title":"Parasit Vectors"},{"key":"key-10.3201\/eid3206.260240-202605150959-R29","doi-asserted-by":"publisher","first-page":"e0114321","DOI":"10.1128\/mBio.01143-21","article-title":"Enhanced virus detection and metagenomic sequencing in patients with meningitis and encephalitis.","volume":"12","author":"Piantadosi","year":"2021","journal-title":"MBio"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:59:52Z","timestamp":1778853592000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/32\/6\/26-0240_intro.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"URL":"https:\/\/doi.org\/10.3201\/eid3206.260240","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}